Research Paper Volume 16, Issue 3 pp 2061—2076
LncRNA MEG3 inhibits the proliferation and migration abilities of colorectal cancer cells by competitively suppressing MiR-31 and reducing the binding of MiR-31 to target gene SFRP1
Figure 7. MEG3 inhibits colon cancer cell proliferation and motility by reducing the binding of miR-31 to the target gene SFRP1. (A) CCK8 test results; (B) The relative protein expression levels of Ki-67, MMP2, and MMP9 in each group were detected using western blotting. **P<0.01.